A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer
Condition:   Prostate Cancer Intervention:   Drug: Neoadjuvant treatment Sponsor:   Johns Hopkins Bloomberg School of Public Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2022 Category: Research Source Type: clinical trials

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)
Condition:   Metastatic Castration-resistant Prostate Cancer Interventions:   Drug: Niraparib plus Abiraterone Acetate (Nira/AA) combination;   Drug: Prednisone/Prednisolone Sponsor:   Janssen Research & Development, LLC Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2022 Category: Research Source Type: clinical trials